首页> 美国卫生研究院文献>Molecular Vision >Optimization of a genotyping screening based on hydrolysis probes to detect the main mutations related to Leber hereditary optic neuropathy (LHON)
【2h】

Optimization of a genotyping screening based on hydrolysis probes to detect the main mutations related to Leber hereditary optic neuropathy (LHON)

机译:基于水解探针的基因分型筛选的优化以检测与莱伯遗传性视神经病变(LHON)相关的主要突变

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

PurposeLeber hereditary optic neuropathy (LHON) is a mitochondrial inherited disease characterized by bilateral vision problems, such as reduced visual acuity, dyschromatopsia, and central or centrocecal scotoma. Of these cases, 95% are caused by three mutations in mitochondrial DNA (mtDNA): m.G11778A, followed by m.T14484C and m.G3460A. The remaining 5% of cases of LHON are caused by rare mutations also present in mtDNA. Although conventional molecular tools for molecular screening of LHON are becoming popular, in most cases these tools are still expensive and time-consuming and are difficult to reproduce. Therefore, to meet the need for more accurate, faster, and cheaper techniques for molecular screening, as well as make it more accessible, we used the high-throughput method TaqMan® OpenArray Genotyping platform for developing a customized high-throughput assay for the three main mutations related to LHON.
机译:目的Leer遗传性视神经病变(LHON)是线粒体遗传的疾病,其特征是双侧视力问题,例如视力下降,色盲,中央或中心盲点。在这些情况下,95%是由线粒体DNA(mtDNA)的三个突变引起的:m.G11778A,其次是m.T14484C和m.G3460A。其余5%的LHON病例是由mtDNA中也存在的罕见突变引起的。尽管用于LHON分子筛查的常规分子工具正在普及,但在大多数情况下,这些工具仍然昂贵且费时且难以复制。因此,为了满足对更精确,更快和更便宜的分子筛查技术的需求,并使其更易于使用,我们使用了高通量方法TaqMan ® OpenArray 基因分型平台,用于开发与LHON相关的三个主要突变的定制高通量检测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号